Article metrics

Download PDFPDF

Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas

 

Online download statistics by month:

Online download statistics by month: February 2018 to April 2020

AbstractFullPdf
Feb 2018640456
Mar 2018712422
Apr 201882839
May 201882838
Jun 201810110215
Jul 2018686812
Aug 2018747411
Sep 201845455
Oct 2018919119
Nov 201874748
Dec 2018535311
Jan 2019666613
Feb 201964648
Mar 2019464411
Apr 2019565413
May 201968657
Jun 201972708
Jul 201960608
Aug 201937377
Sep 201937377
Oct 2019494814
Nov 201930286
Dec 201927279
Jan 202026267
Feb 202023238
Mar 2020323210
Apr 2020242410
Total14001906322